ATE22011T1 - Virusimpfstoffe und verfahren zu ihrer herstellung. - Google Patents

Virusimpfstoffe und verfahren zu ihrer herstellung.

Info

Publication number
ATE22011T1
ATE22011T1 AT82200681T AT82200681T ATE22011T1 AT E22011 T1 ATE22011 T1 AT E22011T1 AT 82200681 T AT82200681 T AT 82200681T AT 82200681 T AT82200681 T AT 82200681T AT E22011 T1 ATE22011 T1 AT E22011T1
Authority
AT
Austria
Prior art keywords
virus vaccines
carbon atoms
manufacture
processes
vaccines
Prior art date
Application number
AT82200681T
Other languages
English (en)
Inventor
Wezel Antonius Ludovicus Van
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of ATE22011T1 publication Critical patent/ATE22011T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/135Foot- and mouth-disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT82200681T 1981-06-05 1982-06-03 Virusimpfstoffe und verfahren zu ihrer herstellung. ATE22011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8102740A NL8102740A (nl) 1981-06-05 1981-06-05 Virusvaccins en werkwijze ter bereiding daarvan.
EP82200681A EP0066932B1 (de) 1981-06-05 1982-06-03 Virusimpfstoffe und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE22011T1 true ATE22011T1 (de) 1986-09-15

Family

ID=19837606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82200681T ATE22011T1 (de) 1981-06-05 1982-06-03 Virusimpfstoffe und verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (1) US4508708A (de)
EP (1) EP0066932B1 (de)
AT (1) ATE22011T1 (de)
CA (1) CA1193545A (de)
DE (1) DE3273145D1 (de)
NL (1) NL8102740A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0110791B1 (de) * 1982-11-30 1990-04-25 Institut Pasteur Immunogen-Lage des Poliovirus enthaltende Peptide und DNS enthaltend Nukleotidfragmente die für diese Peptide kodieren
US4595588A (en) * 1984-05-24 1986-06-17 Board Of Regents, The University Of Texas System Natural inhibitor that protects against viral infections
RU2143921C1 (ru) * 1999-04-21 2000-01-10 Всероссийский научно-исследовательский институт защиты животных Вакцина против ящура типа а и способ ее изготовления
DE10133616A1 (de) * 2001-07-13 2003-01-30 Bosch Rexroth Ag Hydraulische Steueranordnung
RU2294760C2 (ru) * 2004-12-21 2007-03-10 Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ ВНИИЗЖ) Вакцина инактивированная сорбированная против ящура типа а
RU2631129C1 (ru) * 2007-05-21 2017-09-19 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Способ изготовления вакцины против ящура и вакцина против ящура
CN104093420B (zh) 2011-11-03 2017-07-28 森提耐斯特治疗公司 针对人肠道病毒的抗原及疫苗
RU2562547C1 (ru) * 2014-04-16 2015-09-10 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Вакцина инактивированная сорбированная против ящура типа а
RU2699671C1 (ru) * 2019-05-31 2019-09-09 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Вакцина для ранней защиты против ящура типа О инактивированная эмульсионная

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933837A (en) * 1973-07-23 1976-01-20 Sterling Drug Inc. 3,4-Methylenedioxyphenoxy-alkyl diketones and keto-esters
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
CA1067406A (en) * 1976-11-29 1979-12-04 Connaught Laboratories Limited Stabilized oral poliovaccine and stabilizing medium therefor
AU536829B2 (en) * 1979-04-17 1984-05-24 Keith John Stephenson Pegg Hair growth promoter
CA1138773A (en) * 1979-04-18 1983-01-04 George Wojcik Synthetic adjuvants for stimulation of antigenic responses

Also Published As

Publication number Publication date
NL8102740A (nl) 1983-01-03
DE3273145D1 (en) 1986-10-16
CA1193545A (en) 1985-09-17
EP0066932B1 (de) 1986-09-10
EP0066932A1 (de) 1982-12-15
US4508708A (en) 1985-04-02

Similar Documents

Publication Publication Date Title
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
SE441753B (sv) Sett att framstella en skyddad polypeptid med minskad benegenhet till immunicering och bibehallen fysiologisk aktivitet
ATE22011T1 (de) Virusimpfstoffe und verfahren zu ihrer herstellung.
KR920701178A (ko) 3-아릴옥사졸리디논 유도체, 그의 제조방법 및 그의 치료 용도
EP0996037A3 (de) Polyvinylacetale mit Imidgruppen und ihre Verwendung in lichtempfindlichen Zusammensetzungen
DK0915894T3 (da) Nukleotidanaloger
KR900000351A (ko) 1-아릴-나프토일아민 및 그의 제조방법
ES269967A1 (es) Un procedimiento para la preparaciën de pirazolonas sustituidas
EP0262806A3 (de) Organosilikonverbindung
GB1175808A (en) Improvements in or relating to new Therapeutic Composition, new Coumarin Derivatives and their process of preparation
ES8705360A1 (es) Procedimiento para preparar nuevas homoproporgilaminas.
DE60222244D1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
SU544370A3 (ru) Способ получени производных циклопропилфенилпирролидина или их солей
IT1197841B (it) Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione
NO905521L (no) 2-formylbenzylfosfonsyre-derivater, deres fremstilling oganvendelse til behandling av sykdommer som er foraarsaket av virus.
DE69011748D1 (de) Biphenyl-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte.
ATE133955T1 (de) Acylphosphatester und modifikation von proteinen damit
US2489777A (en) Alpha-aminopyridine antifflstaminic
KR870000349A (ko) 포스폰산 유도체의 제조방법
IE780577L (en) Propanolamines
SE8702986D0 (sv) Isokinolinderivat
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
JPS5455544A (en) Pheylacetamide derivatives
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee